海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2015-04-09
Not recruiting
- Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
- Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV);Human Immunodeficiency Virus (HIV)
- Australia, Belgium, Canada, Chile, Colombia, Denmark, Germany, Guatemala, Honduras, Israel, Mexico, Netherlands, New Zealand, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom, United States
- 2015-03-26
Recruiting
- A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
- Hemophilia A;Factor VIII Deficiency;Hemophilia;Hemophilia B;Factor IX Deficiency
- United States
- 2015-01-30
Not recruiting
- T790M Mutation Positive 2nd Line STandard of cAre Registry
- Non Small Cell Lung Cancer
- China, France, Germany, Italy, Netherlands, Russian Federation, Spain, Taiwan, United States
- 2015-01-29
Not recruiting
- Community Central Line Infection Prevention Trial
- Infection
- United States
- 2015-01-27
Not recruiting
- A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
- Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines
- United States
- 2015-01-06
Not recruiting
- A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
- Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines
- United States
- 2015-01-06
Not recruiting
- Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
- Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines
- United States
- 2016-12-22
Not recruiting
- Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
- Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines;Glabellar Frown Lines
- Canada, United States
- 2016-12-22
Not recruiting
- Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
- Glabellar Frown Lines
- Canada, United States
- 2016-12-22
Not recruiting
- Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
- Glabellar Frown Lines (GL);Glabellar Frown Lines (GL);Glabellar Frown Lines (GL);Glabellar Frown Lines (GL)
- United States
- 2016-10-11
Not recruiting
- Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
- Rectal Cancer;Anastomotic Leak;Rectal Cancer;Anastomotic Leak;Rectal Cancer;Anastomotic Leak
- Belgium, Denmark, Israel, Italy, Netherlands, Sweden, United States
- 2016-09-15
Not recruiting
- Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
- Mesothelioma;Pleural Mesothelioma
- United States
- 2016-09-08
Not recruiting
- Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
- Catheter-Related Infections;Catheter-Related Infections;Catheter-Related Infections;Catheter-Related Infections
- United States
- 2016-08-29
Not recruiting
- Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
- Malignant Pleural Mesothelioma
- United States
- 2012-08-23
Not recruiting
- A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
- Advanced Solid Tumor;Lymphoma
- United States
- 2012-04-26
Not recruiting
- Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease
- Breast Cancer;Cervical Cancer;Endometrial Cancer;Ovarian Cancer;Primary Peritoneal Carcinoma;Bone Sarcoma;Cancer;Solid Tumor;Breast Cancer;Cervical Cancer;Endometrial Cancer;Ovarian Cancer;Primary Peritoneal Carcinoma;Bone Sarcoma;Cancer;Solid Tumor;Breast Cancer;Cervical Cancer;Endometrial Cancer;Ovarian Cancer;Primary Peritoneal Carcinoma;Bone Sarcoma;Cancer;Solid Tumor;Breast Cancer;Cervical Cancer;Endometrial Cancer;Ovarian Cancer;Primary Peritoneal Carcinoma;Bone Sarcoma;Cancer;Solid Tumor
- United States
- 2012-04-20
Not recruiting
- Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
- Liver Cancer;Pancreatic Cancer;Liver Cancer;Pancreatic Cancer;Liver Cancer;Pancreatic Cancer;Liver Cancer;Pancreatic Cancer
- United States
- 2012-04-18
Not recruiting
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
- Neurofibromatosis Type 1;Recurrent Childhood Pilocytic Astrocytoma;Recurrent Childhood Visual Pathway Glioma
- Australia, Canada, New Zealand, United States
- 2012-03-10
Not recruiting
- Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
- Infection
- United States
- 2012-02-17
